Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
CFO AND TREASURER · UNITED THERAPEUTICS Corp · UNITED THERAPEUTICS Corp — Stock Option
Option exercise — administrative, little informational value
No reported dollar value · 16.0% of prior position
Disclosed 1 business day after execution (deadline: 2)
Routine: 19 prior trades recorded in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 10 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $47K 80 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $166K 280 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $182K 310 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $184K 320 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 10 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $46K 80 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $311K 539 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $186K 320 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $89K 156 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $184K 320 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 10 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $48K 80 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $127K 221 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $321K 562 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $95K 160 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $183K 306 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 10 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $5,998 10 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $215K 375 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $100K 167 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $142K 237 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 8 | Rothblatt Martine ADirector, Chairperson & CEO | Option exercise · 10b5-1 plan | M | $1.12M 9,500 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 3 | Rothblatt Martine ADirector, Chairperson & CEO | Option exercise · 10b5-1 plan | M | — 9,500 sh | Nov 6, 2026 traded Nov 5, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Edgemond James filed this Form 4 reporting a option exercise of UTHR on Apr 20, 2026. It became public on Apr 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.